ConductScience.org, home

Paper6403580

Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

Rosenfeld SI and 2 others. J Clin Invest, 1983. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins. Papers, record 6403580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6403580

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
PubMed
Journal
J Clin Invest
PubMed
Year
1983
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2019-06-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosenfeld SIS I
2Packman CHC H
3Leddy JPJ P

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApolipoproteinsMajor topic
Complement Inactivator ProteinsMajor topic
Complement System ProteinsMajor topic
Lipoproteins, HDLMajor topic
Animals
Apolipoprotein A-I
Apolipoprotein A-II
Complement C9
Complement Membrane Attack Complex
Edetic Acid
Electrophoresis, Polyacrylamide Gel
Guinea Pigs
Hemolysis
Humans
Lipids
Receptors, Complement
Sheep

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01-HL-18208NHLBI NIH HHSUnited StatesP01HL018208PubMed and NIHNIH RePORTER
P50-AI-15372NIAID NIH HHSUnited StatesP50AI015372PubMed and NIHNIH RePORTER
R01-AI-16089NIAID NIH HHSUnited StatesR01AI016089PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01524705FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)Background

Source ClinicalTrials.gov

Download CSV of trials

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1116784Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.Clin Exp Immunol1979https://conductscience.org/library/papers/116784PubMed
26766971The ninth component of human complement: purification and physicochemical characterization.J Immunol1980https://conductscience.org/library/papers/6766971PubMed
37373347Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.J Neuropathol Exp Neurol1980https://conductscience.org/library/papers/7373347PubMed
47430624Mechanism of lethal effect of human serum upon Leishmania donovani.J Immunol1980https://conductscience.org/library/papers/7430624PubMed
57430645Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9.J Immunol1980https://conductscience.org/library/papers/7430645PubMed
67462623Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids.J Immunol1981https://conductscience.org/library/papers/7462623PubMed
77204557New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma.J Clin Invest1981https://conductscience.org/library/papers/7204557PubMed
87217673Immunosuppressive effect of mouse serum lipoproteins. I. In vitro studies.J Immunol1981https://conductscience.org/library/papers/7217673PubMed
96786293Human plasma high density apolipoprotein A-I: effect of protein-protein interactions on the spontaneous formation of a lipid-protein recombinant.Biochem Biophys Res Commun1981https://conductscience.org/library/papers/6786293PubMed
107240749The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.J Immunol1981https://conductscience.org/library/papers/7240749PubMed
116946459Homologous species restriction in lysis of erythrocytes by terminal complement proteins.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6946459PubMed
127033435Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis.J Exp Med1981https://conductscience.org/library/papers/7033435PubMed
137054697Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.N Engl J Med1982https://conductscience.org/library/papers/7054697PubMed
146177822Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.J Exp Med1982https://conductscience.org/library/papers/6177822PubMed
156776186Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.J Immunol1980https://conductscience.org/library/papers/6776186PubMed
167094437Evidence for antibody-dependent binding of the terminal complement component to alveolar basement membrane.Clin Immunol Immunopathol1982https://conductscience.org/library/papers/7094437PubMed
1714265901STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. II. RESOLUTION OF THE E TRANSFORMATION REACTION INTO MULTIPLE STEPS.J Immunol1965https://conductscience.org/library/papers/14265901PubMed
195960883Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.Immunochemistry1966https://conductscience.org/library/papers/5960883PubMed
206051385Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.J Immunol1967https://conductscience.org/library/papers/6051385PubMed
214980192Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.Biochemistry1969https://conductscience.org/library/papers/4980192PubMed

See all 49 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
39405051Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration.Invest Ophthalmol Vis Sci2024https://conductscience.org/library/papers/39405051PubMed
36531576Relationships between Lipid-Related Metabolites and Age-Related Macular Degeneration Vary with Complement Genotype.Ophthalmol Sci2022https://conductscience.org/library/papers/36531576PubMed
33228032High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma.Int J Mol Sci2020https://conductscience.org/library/papers/33228032PubMed
32331355High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases.Biomolecules2020https://conductscience.org/library/papers/32331355PubMed
31153037HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation.Redox Biol2019https://conductscience.org/library/papers/31153037PubMed
30310426Cholesteryl Ester Transfer Protein Inhibitors - Future Soon to be REVEALed.Eur Cardiol2015https://conductscience.org/library/papers/30310426PubMed
26634153Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics.Cholesterol2015https://conductscience.org/library/papers/26634153PubMed
23434634Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.J Lipid Res2013https://conductscience.org/library/papers/23434634PubMed
23431458High-density lipoproteins and the immune system.J Lipids2013https://conductscience.org/library/papers/23431458PubMed
21896489Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3.J Biol Chem2011https://conductscience.org/library/papers/21896489PubMed
21394116Complement in age-related macular degeneration: a focus on function.Eye (Lond)2011https://conductscience.org/library/papers/21394116PubMed
20847305Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.Arterioscler Thromb Vasc Biol2010https://conductscience.org/library/papers/20847305PubMed
19738003Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins.J Lipid Res2009https://conductscience.org/library/papers/19738003PubMed
17315398Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.Vasc Health Risk Manag2005https://conductscience.org/library/papers/17315398PubMed
12930163Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.Drugs2003https://conductscience.org/library/papers/12930163PubMed
12603605An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.Immunology2003https://conductscience.org/library/papers/12603605PubMed
12458630Apolipoproteins A-I and A-II downregulate neutrophil functions.Lipids2002https://conductscience.org/library/papers/12458630PubMed
8485805Identification of serum components that inhibit the tumoricidal activity of amphiphilic alpha helical peptides.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8485805PubMed
8348751
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.
Clin Exp Immunol1993https://conductscience.org/library/papers/8348751PubMed
7519171High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma.Immunology1994https://conductscience.org/library/papers/7519171PubMed

See all 27 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOA1335PubTator's text mininghttps://conductscience.org/library/genes/335NCBI Gene
APOA2336PubTator's text mininghttps://conductscience.org/library/genes/336NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6403580

GET https://conductscience.org/api/papers/v1/6403580/references?page=2